OSE Immunotherapeutics (XPAR:OSE) Accounts Payable : €6.36 Mil (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is OSE Immunotherapeutics Accounts Payable?

OSE Immunotherapeutics's Accounts Payable for the quarter that ended in Dec. 2023 was €6.36 Mil.

OSE Immunotherapeutics's quarterly Accounts Payable increased from Dec. 2022 (€4.56 Mil) to Jun. 2023 (€9.42 Mil) but then declined from Jun. 2023 (€9.42 Mil) to Dec. 2023 (€6.36 Mil).

OSE Immunotherapeutics's annual Accounts Payable increased from Dec. 2021 (€2.96 Mil) to Dec. 2022 (€4.56 Mil) and increased from Dec. 2022 (€4.56 Mil) to Dec. 2023 (€6.36 Mil).

OSE Immunotherapeutics Accounts Payable Historical Data

The historical data trend for OSE Immunotherapeutics's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OSE Immunotherapeutics Accounts Payable Chart

OSE Immunotherapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

Get a 7-Day Free Trial

4.28

7.39

2.96

4.56

6.36

OSE Immunotherapeutics Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Payable	Get a 7-Day Free Trial															2.96	13.63	4.56	9.42	6.36

OSE Immunotherapeutics Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

OSE Immunotherapeutics Accounts Payable Related Terms

Thank you for viewing the detailed overview of OSE Immunotherapeutics's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

OSE Immunotherapeutics (XPAR:OSE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OSE Immunotherapeutics SA (XPAR:OSE) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

6OP:Germany

Address

22, Boulevard Benoni Goullin, Nantes, FRA, 44200

Website

http://www.ose-immuno.com

OSE Immunotherapeutics SA is a France-based biotechnology company focused on the development of immunotherapies for immune activation and regulation in the fields of immuno-oncology and autoimmune diseases. The product portfolio of the company comprises Tedopi, OSE-172, OSE-703, FR104 and OSE-127.

OSE Immunotherapeutics (XPAR:OSE) Headlines

No Headlines